Biederman's Contribution to the Understanding of Executive Function in ADHD.


Journal

Journal of attention disorders
ISSN: 1557-1246
Titre abrégé: J Atten Disord
Pays: United States
ID NLM: 9615686

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 12 3 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: ppublish

Résumé

To examine the theoretical and empirical contribution of Joe Biederman and his colleagues to the understanding of executive function (EF) and ADHD. We searched PubMed for references to EF in Biederman's publications and conducted a narrative review of this literature. In 50 or more papers using neuropsychological tests, rating scales and measures of mind wandering, Biederman demonstrated that EF are evident in ADHD and closely linked to its underlying neurobiological and genetic risk. He argued that EF need to be monitoring to ensure comprehensive assessment and treatment, but could not be used as a diagnostic proxy. Biederman built an innovative and impressive collaboration to address the issue of EF in ADHD. His work shows a commitment to understanding of EF in order to improve patient care. Biederman laid down a roadmap for research in ADHD and EF for the rest of the field to follow.

Identifiants

pubmed: 38327019
doi: 10.1177/10870547231222597
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

895-904

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Russell Schachar (R)

Neuroscicences and Mental Health, Department of Psychiatry, The Hospital for Sick Children, University of Toronto, ON, Canada.

Jennifer Crosbie (J)

Neuroscicences and Mental Health, Department of Psychiatry, The Hospital for Sick Children, University of Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH